Preservation of pregnancy in a patient with a stage IIIB ovarian epithelial carcinoma diagnosed at 22 weeks of cancer peritoneal secondary and treated with initial chemotherapy: case report and literature review.
Gynecol Oncol ; Transfer of drugs and other chemicals into human milk.
Pediatrics ; Doxorubicin and cisplatin excretion into human milk. Cancer Treat Rep ; Benefit of palliative surgery for bowel obstruction in advanced ovarian cancer. Can J Surg ; The role of secondary cytoreductive surgery for recurrent ovarian cancer.
Advanced epithelial ovarian cancer: consensus statements. Ann Oncol ; 10 Suppl Secondary cytoreductive surgery in patients with platinumsensitive recurrent ovarian cancer.
Ann Surg Oncol ; Critical evaluation of secondary cytoreduction in recurrent ovarian cancer. Secondary cytoreductive surgery for recurrent epithelial ovarian carcinoma: proposal for patients selection. Br J Cancer ; Secondary cytoreductive surgery for localized, recurrent epithelial ovarian cancer: analysis of prognostic factors and survival outcome.
- Cervical cancer yeast infection
- Treatment of Peritoneal Surface Malignancies: Angelo Di Giorgio · | Books Express
- Managementul perioperator al unui pacient cu tumoră Krukenberg - studiu de caz
Cancer ; Guidelines and selection criteria for secondary cytoreductive surgery in patients with recurrent, platinum-sensitive epithelial ovarian carcinoma.
Cytoreductive surgery for patients with recurrent epithelial ovarian carcinoma.
Secondary cytoreductive surgery for isolated nodal recurrence in patients with epithelial ovarian cancer. Surgery for the resolution of symptoms in malignant bowel obstruction in advanced gynaecological and gastrointestinal cancer Cochrane Review.
Palliative surgery for bowel obstruction in recurrent ovarian cancer: an updated series. Gastrointestinal surgery in patients with ovarian cancer.
Percutaneous endoscopic gastrostomy tube placement in patients with malignant bowel obstruction due to ovarian carcinoma. Duration of response to second-lineplatinum-based chemotherapy for ovarian cancer: implications for patient management and clinical trial design.
J Clin Oncol ; Does palliative chemotherapy palliate? Evaluation of expectations, outcomes, and costs in women receiving chemotherapy for advanced ovarian cancer. Response of patients in phase II studies of chemotherapy in ovarian cancer: implications for patient treatement and the design of phase II trials. Br J Cancer ; 59 4 cancer testicule ldh Randomised controlled trial of single-agent paclitaxel versus cyclophosphamide, doxorubicin, and cisplatin in patients with recurrent ovarian cancer who responded to firs-line platinum-based regimens.
J Clin Hpv qui persiste ; 20 5 Randomized controlled trial of single-agent paclitaxel versus cyclophosphamide, Doxorubicin, and Cisplatin in patients with recurrent ovarian cancer who responded to first-line platinum-based regimens.
Docetaxel and oxaliplatin in the second-line treatment of platinum-sensitive recurrent ovarian cancer: a phase II study.
V-ar putea interesa
Ann Oncol J Clin Oncol ; s. Abstract available online at www. Paclitaxel vs epidoxorubicin plus paclitaxel as second-line therapy for platinum-refractory and -resistant ovarian cancer. European-Canadian randomized trial of paclitaxel in relapsed ovarian cancer: high-dose versus low-dose and long versus short infusion.
- Cristian Iorga - Google Scholar Citations
- Human papiloma virus lesions
- It is important to distinguish between primary ovarian cancer and metastatic tumors in the ovary because their management is different, in terms of treatment and follow-up.
- Skin papilloma excision
- Revista Romana de Anatomie
Weekly docetaxel and carboplatin for recurrent ovarian and peritoneal cancer: a phase II trial. Prolonged oral etoposide as second-line therapy for platinum-resistant and platinum-sensitive ovarian carcinoma: a Gynecologic Oncology Group study. Recurrent epithelial ovarian carcinoma: a randomized phase III study of pegylated liposomal doxorubicin versus topotecan.
Peritoneal Metastases from Colorectal Cancer: Is a Cure Possible?
Liposomal doxorubicin in ovarian, peritoneal, and tubal carcinoma: a retrospective comparative study of single-agent dosages. Oral topotecan as single-agent second-line chemotherapy in patients with advanced ovarian cancer.
Managementul perioperator al unui pacient cu tumoră Krukenberg - studiu de caz
Williams CJ, Simera I. Tamoxifen for relapse of ovarian cancer Cochrane Review. In: The Cochrane Library, Issue 1, Oxford: Update Software. Urmărire şi monitorizare 1. Ultrasoundphysical examination, and CA measurement for the detection of recurrence after conservative surgery for early borderline ovarian tumors. Gynecol Cancer peritoneal secondary ; 81 cancer peritoneal secondary Management of ovarian cancer: referral to a multidisciplinary team matters.
Cancer peritoneal secondary J Cancer ; 70 2